The 2012 Cancer Genome Atlas study showed that GSK3B was amplified at a frequency of 6.7% (12/178 profiled samples) in NSCLC patients with a squamous cell carcinoma histological subtype [45]. Here, GSK3B is linked to non-small cell lung carcinoma.